Acquisition Channel Glooko's acquisition of Monarch Medical Technologies expands the hospital market footprint, enabling cross-sell of EndoTool's inpatient insulin dosing with Glooko's glycemic safety platform across the care continuum. Target plan: map Glooko enterprise accounts and present a joint value proposition to hospital systems, IDNs, and clinically integrated networks; emphasize EndoTool's patient-specific dosing and the new EndoX 3 dosing mode as differentiators; propose joint marketing and clinical pilots.

Regulatory Advantage EndoTool IV 3.1 with dosing mode received FDA 510(k) clearance and includes EndoX 3 to support insulin dosing during hyperglycemic crises (EuDKA, DKA, HHNK). This positions Monarch/Glooko as a compliant, safety-focused option for hospital diabetes programs and critical care units. Sales approach: target hospital diabetes programs, pharmacy and critical care leaders, and risk/compliance officers with ROI on improved glycemic outcomes and regulatory alignment.

Adoption Network EndoTool Community launched to improve access to resources and optimize tool usage. This creates upsell opportunities for training, premium support, and enterprise licensing, plus an onboarding pathway for new hospital customers. BD play: offer bundled training packages and implementation support to hospitals adopting EndoTool within Glooko's platform.

Financial Growth Company revenue in the tens of millions and a $5 million funding round signal a scalable product and credible backing. Use this to approach mid-market hospitals and IDNs with a credible ROI story, and propose phased deployments, pilot programs, and performance-based pricing to accelerate adoption in hospital settings.

Platform Synergy Being part of Glooko enables cross-selling between inpatient EndoTool and outpatient diabetes management workflows, enabling a unified glycemic care platform across care settings. BD angle: propose integrated contracts with hospital systems that aim to centralize diabetes management, present a joint value proposition to procurement, and highlight interoperability with common tech stacks and IT ecosystems.